U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H44O
Molecular Weight 384.6377
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 7-DEHYDROCHOLESTEROL

SMILES

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

InChIKey=UCTLRSWJYQTBFZ-DDPQNLDTSA-N
InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1

HIDE SMILES / InChI

Molecular Formula C27H44O
Molecular Weight 384.6377
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
[New relevance of vitamin D3 metabolism in the skin].
2004-05
Effect of sterols on beta-amyloid peptide (AbetaP 1-40) channel formation and their properties in planar lipid membranes.
2004-04
Investigation of completed suicide and genes involved in cholesterol metabolism.
2004-04
Founder effect for the T93M DHCR7 mutation in Smith-Lemli-Opitz syndrome.
2004-03-01
A novel mutation of the human 7-dehydrocholesterol reductase gene reduces enzyme activity in patients with holoprosencephaly.
2004-02-27
Late gestational lung hypoplasia in a mouse model of the Smith-Lemli-Opitz syndrome.
2004-02-02
Antenatal manifestations of Smith-Lemli-Opitz (RSH) syndrome: a retrospective survey of 30 cases.
2004-02-01
Effect of clothing varieties on solar photosynthesis of previtamin D3: an in vitro study.
2004-02
Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.
2004-02
Synthesis of vitamin D in skin after burns.
2004-01-24
The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production.
2004-01
MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome.
2004-01
Novel sterols synthesized via the CYP27A1 metabolic pathway.
2003-12-01
Identification of natural ligands of retinoic acid receptor-related orphan receptor alpha ligand-binding domain expressed in Sf9 cells--a mass spectrometry approach.
2003-12-01
Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism.
2003-12
Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease.
2003-11-15
What controls variation in human skin color?
2003-10
Diagnosis of Smith-Lemli-Opitz syndrome by ultraviolet spectrophotometry.
2003-10
Identification of three patients with a very mild form of Smith-Lemli-Opitz syndrome.
2003-09-15
Versatile photosensitization system for 1O2-mediated oxidation of alkenes based on nafion-supported platinum(II) terpyridyl acetylide complex.
2003-09-04
27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway.
2003-08
Chemical and photolytical transformation of biomedically significant compounds in the presence of deuterated solvents.
2003-07-10
Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency.
2003-07-01
Susceptibilities of phospholipid vesicles containing different sterols to amphotericin B-loaded lysophosphatidylcholine micelles.
2003-07
Smith-Lemli-Opitz syndrome and the DHCR7 gene.
2003-05
Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis.
2003-04
Yeast-like symbiotes as a sterol source in anobiid beetles (Coleoptera, Anobiidae): possible metabolic pathways from fungal sterols to 7-dehydrocholesterol.
2003-04
Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP.
2003-01-30
[Clinical characteristics and diagnosis of Smith-Lemli-Opitz syndrome and tentative phenotype-genotype correlation: report of 45 cases].
2003-01
Extrarenal sites of calcitriol synthesis: the particular role of the skin.
2003
Smith-Lemli-Opitz syndrome: a review, case report and dental implications.
2003
Protein prenyltransferases.
2003
Simvastatin treatment in the SLO syndrome: a safe approach?
2002-11-22
Biochemical abnormality associated with Smith-Lemli-Opitz syndrome in an infant with features of Rutledge multiple congenital anomaly syndrome confirms that the latter is a variant of the former.
2002-11-06
Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith-Lemli-Opitz syndrome.
2002-10
Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
2002-10
Ternary gradient elution markedly improves silver-ion high performance liquid chromatography of unsaturated sterols.
2002-10
Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase.
2002-10
Greenberg dysplasia (hydrops-ectopic calcification-moth-eaten skeletal dysplasia): prenatal ultrasound diagnosis and review of literature.
2002-09-01
Molecular prenatal diagnosis of Smith-Lemli-Opitz syndrome is reliable and efficient.
2002-09
Two novel mutations of the human delta7-sterol reductase (DHCR7) gene in children with Smith-Lemli-Opitz syndrome.
2002-08
Stimulative effects of (22E,24R)-ergosta-7,22-diene-3beta,5alpha,6beta-triol from fruiting bodies of Tricholoma auratum, on a mouse osteoblastic cell line, MC3T3-E1.
2002-08
Cholesterol induce oligomerization of Vibrio vulnificus cytolysin specifically.
2002-07-31
Unbalanced translocation (3;5)(q26.1;p14): a clinical report.
2002-07-15
Novel mutation in the Delta-sterol reductase gene in three Lebanese sibs with Smith-Lemli-Opitz (RSH) syndrome.
2002-06-15
Structure and alternative splicing of the rat 7-dehydrocholesterol reductase gene.
2002-06-07
Smith-Lemli-Opitz syndrome: carrier frequency and spectrum of DHCR7 mutations in Canada.
2002-06
A colorimetric assay for 7-dehydrocholesterol with potential application to screening for Smith-Lemli-Opitz syndrome.
2002-05
Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts.
2002-04
Evolution of UV-B regulation and protection in plants.
2002
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:28:10 GMT 2025
Edited
by admin
on Mon Mar 31 19:28:10 GMT 2025
Record UNII
BK1IU07GKF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-18159
Preferred Name English
7-DEHYDROCHOLESTEROL
INCI  
INCI  
Official Name English
(3.BETA.)-7-DEHYDROCHOLESTEROL [MI]
Common Name English
9.BETA.,10.ALPHA.-CHOLESTA-5,7-DIEN-3.BETA.-OL
Systematic Name English
CHOLESTA-5,7-DIEN-3.BETA.-OL
Systematic Name English
CHOLECALCIFEROL IMPURITY B [EP IMPURITY]
Common Name English
Classification Tree Code System Code
LOINC 50799-6
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
LOINC 48610-0
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
LOINC 40597-7
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
LOINC 33275-9
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
LOINC 46700-1
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
LOINC 22676-1
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
LOINC 32289-1
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
Code System Code Type Description
WIKIPEDIA
7-Dehydrocholesterol
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
RXCUI
1362616
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY RxNorm
FDA UNII
BK1IU07GKF
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-100-5
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
EPA CompTox
DTXSID20861933
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
CHEBI
17759
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
CAS
434-16-2
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
MERCK INDEX
m4141
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY Merck Index
NSC
18159
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
PUBCHEM
439423
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
MESH
C016705
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
DAILYMED
BK1IU07GKF
Created by admin on Mon Mar 31 19:28:10 GMT 2025 , Edited by admin on Mon Mar 31 19:28:10 GMT 2025
PRIMARY
Related Record Type Details
METABOLITE -> PARENT
METABOLITE ACTIVE -> PARENT
Formed from UV radiation during exposure to ultraviolet rays of sunlight (wavelengths 290–320 nm).
METABOLITE ACTIVE -> PARENT